Literature DB >> 33390849

The emerging roles of m6A modification in liver carcinogenesis.

Xue-Yin Pan1,2,3, Cheng Huang1,2,3, Jun Li1,2,3.   

Abstract

The 'epitranscriptome', a collective term for chemical modifications that influence the structure, metabolism, and functions of RNA, has recently emerged as vitally important for the regulation of gene expression. N6-methyladenosine (m6A), the most prevalent mammalian mRNA internal modification, has been demonstrated to have a pivotal role in almost all vital bioprocesses, such as stem cell self-renewal and differentiation, heat shock or DNA damage response, tissue development, and maternal-to-zygotic transition. Hepatocellular carcinoma (HCC) is prevalent worldwide with high morbidity and mortality because of late diagnosis at an advanced stage and lack of effective treatment strategies. Epigenetic modifications including DNA methylation and histone modification have been demonstrated to be crucial for liver carcinogenesis. However, the role and underlying molecular mechanism of m6A in liver carcinogenesis are mostly unknown. In this review, we summarize recent advances in the m6A region and how these new findings remodel our understanding of m6A regulation of gene expression. We also describe the influence of m6A modification on liver carcinoma and lipid metabolism to instigate further investigations of the role of m6A in liver biological diseases and its potential application in the development of therapeutic strategies. © The author(s).

Entities:  

Keywords:  Epitranscriptome; Hepatocellular Carcinoma (HCC); N6-methyladenosine

Mesh:

Substances:

Year:  2021        PMID: 33390849      PMCID: PMC7757034          DOI: 10.7150/ijbs.50003

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


  171 in total

1.  YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.

Authors:  Chuanzhao Zhang; Shanzhou Huang; Hongkai Zhuang; Shiye Ruan; Zixuan Zhou; Kaijun Huang; Fei Ji; Zuyi Ma; Baohua Hou; Xiaoshun He
Journal:  Oncogene       Date:  2020-05-04       Impact factor: 9.867

2.  Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis.

Authors:  Phillip J Hsu; Yunfei Zhu; Honghui Ma; Yueshuai Guo; Xiaodan Shi; Yuanyuan Liu; Meijie Qi; Zhike Lu; Hailing Shi; Jianying Wang; Yiwei Cheng; Guanzheng Luo; Qing Dai; Mingxi Liu; Xuejiang Guo; Jiahao Sha; Bin Shen; Chuan He
Journal:  Cell Res       Date:  2017-08-15       Impact factor: 25.617

3.  METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing.

Authors:  Jin-Zhao Ma; Fu Yang; Chuan-Chuan Zhou; Feng Liu; Ji-Hang Yuan; Fang Wang; Tian-Tian Wang; Qing-Guo Xu; Wei-Ping Zhou; Shu-Han Sun
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

4.  VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.

Authors:  Daniel Delgado-Bellido; Mónica Fernández-Cortés; María Isabel Rodríguez; Santiago Serrano-Sáenz; Arkaitz Carracedo; Angel Garcia-Diaz; F Javier Oliver
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

5.  RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated.

Authors:  Atsushi Tanabe; Kenya Tanikawa; Mai Tsunetomi; Kaori Takai; Hiroto Ikeda; Junpei Konno; Toshihiko Torigoe; Hideki Maeda; Goro Kutomi; Kenji Okita; Mitsuru Mori; Hiroeki Sahara
Journal:  Cancer Lett       Date:  2016-03-17       Impact factor: 8.679

6.  SIRT1 Regulates N6 -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation.

Authors:  Xiaoming Liu; Jianye Liu; Wen Xiao; Qinghai Zeng; Hao Bo; Yuxing Zhu; Lian Gong; Dong He; Xiaowei Xing; Ruhong Li; Ming Zhou; Wei Xiong; Yanhong Zhou; Jianda Zhou; Xiaohui Li; Fei Guo; Canxia Xu; Xiong Chen; Xiaoyan Wang; Fen Wang; Qiang Wang; Ke Cao
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

7.  Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome.

Authors:  Bastian Linder; Anya V Grozhik; Anthony O Olarerin-George; Cem Meydan; Christopher E Mason; Samie R Jaffrey
Journal:  Nat Methods       Date:  2015-06-29       Impact factor: 28.547

8.  Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.

Authors:  Philip Knuckles; Tina Lence; Irmgard U Haussmann; Dominik Jacob; Nastasja Kreim; Sarah H Carl; Irene Masiello; Tina Hares; Rodrigo Villaseñor; Daniel Hess; Miguel A Andrade-Navarro; Marco Biggiogera; Mark Helm; Matthias Soller; Marc Bühler; Jean-Yves Roignant
Journal:  Genes Dev       Date:  2018-03-13       Impact factor: 11.361

9.  Single-base mapping of m6A by an antibody-independent method.

Authors:  Zhang Zhang; Li-Qian Chen; Yu-Li Zhao; Cai-Guang Yang; Ian A Roundtree; Zijie Zhang; Jian Ren; Wei Xie; Chuan He; Guan-Zheng Luo
Journal:  Sci Adv       Date:  2019-07-03       Impact factor: 14.136

10.  DART-seq: an antibody-free method for global m6A detection.

Authors:  Kate D Meyer
Journal:  Nat Methods       Date:  2019-09-23       Impact factor: 28.547

View more
  9 in total

1.  Fusaric acid induces hepatic global m6A RNA methylation and differential expression of m6A regulatory genes in vivo - a pilot study.

Authors:  Terisha Ghazi; Savania Nagiah; Anil A Chuturgoon
Journal:  Epigenetics       Date:  2021-09-13       Impact factor: 4.861

2.  Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice.

Authors:  Xuan Su; Yan Shen; Yue Jin; Il-Man Kim; Neal L Weintraub; Yaoliang Tang
Journal:  Front Pharmacol       Date:  2021-08-03       Impact factor: 5.810

3.  Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model.

Authors:  Yue Zhang; Fanhong Zeng; Min Zeng; Xu Han; Lei Cai; Jiajun Zhang; Jun Weng; Yi Gao
Journal:  Int J Biol Sci       Date:  2021-08-14       Impact factor: 6.580

Review 4.  Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification.

Authors:  Anastasiya Kostyusheva; Sergey Brezgin; Dieter Glebe; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

5.  29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses.

Authors:  Ming Liu; Keman Xu; Fatma Saaoud; Ying Shao; Ruijing Zhang; Yifan Lu; Yu Sun; Charles Drummer; Li Li; Sheng Wu; Satya P Kunapuli; Gerard J Criner; Jianxin Sun; Huimin Shan; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  J Immunol Res       Date:  2022-02-15       Impact factor: 4.818

6.  An N6-methyladenosine-associated lncRNA signature for predicting clinical outcome and therapeutic responses in hepatocellular carcinoma.

Authors:  Danjun Song; Yingming Tian; Jun Luo; Guoliang Shao; Jiaping Zheng
Journal:  Ann Transl Med       Date:  2022-04

7.  Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.

Authors:  Tianxing Dai; Jing Li; Linsen Ye; Haoyuan Yu; Mingbin Deng; Wei Liu; Hua Li; Yang Yang; Guoying Wang
Journal:  J Clin Transl Hepatol       Date:  2021-07-13

8.  FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.

Authors:  Xiaojie Gan; Zhihui Dai; Chunmei Ge; Haozan Yin; Yuefan Wang; Jian Tan; Shuhan Sun; Weiping Zhou; Shengxian Yuan; Fu Yang
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

Review 9.  The Role of N6 -Methyladenosine Modified Circular RNA in Pathophysiological Processes.

Authors:  Mei Tang; Yonggang Lv
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.